Biomarkers in the diagnosis and treatment of Covid-19

Abstract

Biomarkers are the biological indicators found in body tissue or fluids and can be considered to diagnose any abnormal condition or disease and as a therapeutic target. Identification and clinical application of diverse biomarkers are needed to track the evolution of disease, predict the course of disease, and to monitor patient response to most treatments. Patients with COVID-19 have been observed to have elevated levels of certain biomarkers. Some of the biomarkers related to covid diagnosis and treatment are Serum Ferritin, Procalcitonin, D dimer, Interleukin-6, Serum Amyloid etc. Various studies have shown that biomarkers can help assess covid seriousness as well. The availability and feasibility of using these biomarkers is sometimes challenging. Our study aimed to focus on the identification of biomarkers in the diagnosis and treatment of COVID-19.